NM_004946.3:c.5425A>G
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_004946.3(DOCK2):c.5425A>G(p.Thr1809Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000176 in 1,613,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004946.3 missense
Scores
Clinical Significance
Conservation
Publications
- DOCK2 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004946.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DOCK2 | NM_004946.3 | MANE Select | c.5425A>G | p.Thr1809Ala | missense | Exon 51 of 52 | NP_004937.1 | ||
| DOCK2 | NR_156756.1 | n.5528A>G | non_coding_transcript_exon | Exon 52 of 53 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DOCK2 | ENST00000520908.7 | TSL:2 MANE Select | c.5425A>G | p.Thr1809Ala | missense | Exon 51 of 52 | ENSP00000429283.3 | ||
| DOCK2 | ENST00000524185.5 | TSL:1 | n.*2380A>G | non_coding_transcript_exon | Exon 52 of 53 | ENSP00000428850.1 | |||
| DOCK2 | ENST00000524185.5 | TSL:1 | n.*2380A>G | 3_prime_UTR | Exon 52 of 53 | ENSP00000428850.1 |
Frequencies
GnomAD3 genomes AF: 0.00101 AC: 153AN: 152176Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000267 AC: 67AN: 250796 AF XY: 0.000207 show subpopulations
GnomAD4 exome AF: 0.0000896 AC: 131AN: 1461606Hom.: 0 Cov.: 34 AF XY: 0.0000839 AC XY: 61AN XY: 727098 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00100 AC: 153AN: 152294Hom.: 0 Cov.: 31 AF XY: 0.00103 AC XY: 77AN XY: 74460 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.5425A>G (p.T1809A) alteration is located in exon 51 (coding exon 51) of the DOCK2 gene. This alteration results from a A to G substitution at nucleotide position 5425, causing the threonine (T) at amino acid position 1809 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
DOCK2-related disorder Uncertain:1
The DOCK2 c.5425A>G variant is predicted to result in the amino acid substitution p.Thr1809Ala. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.38% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/5-169508983-A-G). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
DOCK2 deficiency Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at